These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29530714)

  • 141. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.
    Fu Y; Yang S; Jeong SH; Kimura S; Park K
    Crit Rev Ther Drug Carrier Syst; 2004; 21(6):433-76. PubMed ID: 15658933
    [TBL] [Abstract][Full Text] [Related]  

  • 142. The preparation, characterization, and application of porous core-shell composite particles produced with laboratory-scale spray dryer.
    Li Z; Zhu L; Chen FC; Guan YM; Chen LH; Zhang JW; Mao ZX; Ming LS; Zhu WF
    Drug Dev Ind Pharm; 2023 Feb; 49(2):217-231. PubMed ID: 36994666
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Studies on internal structure of tablets. VI. stress dispersion in tablets by excipients.
    Yuasa H; Akutagawa M; Hashizume T; Kanaya Y
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):378-82. PubMed ID: 8998842
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation.
    Tashan E; Karakucuk A; Celebi N
    AAPS PharmSciTech; 2020 Apr; 21(3):115. PubMed ID: 32296987
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Development and Evaluation of Orodispersible Tablets Containing Ketoprofen.
    Oliveira LJ; Veiga A; Stofella NCF; Cunha AC; da Graça T Toledo M; Andreazza IF; Murakami FS
    Curr Drug Deliv; 2020; 17(4):348-360. PubMed ID: 32183668
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Effects of Functional Biomaterials on the Attributes of Orally Disintegrating Tablets Loaded with Furosemide Nanoparticles: In Vitro and In Vivo Evaluations.
    Alshora D; Alyousef W; Ibrahim M
    J Funct Biomater; 2024 Jun; 15(6):. PubMed ID: 38921534
    [TBL] [Abstract][Full Text] [Related]  

  • 147. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach.
    Wang C; Sun CC
    Int J Pharm; 2020 Nov; 589():119816. PubMed ID: 32877727
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin.
    Singh J; Philip AK; Pathak K
    AAPS PharmSciTech; 2008; 9(1):60-6. PubMed ID: 18446462
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Development of an In Vitro Methodology to Assess the Bioequivalence of Orally Disintegrating Tablets Taken without Water.
    Takagi T; Masada T; Minami K; Kataoka M; Yamashita S
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765162
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Continuous downstream processing of milled electrospun fibers to tablets monitored by near-infrared and Raman spectroscopy.
    Szabó E; Záhonyi P; Gyürkés M; Nagy B; Galata DL; Madarász L; Hirsch E; Farkas A; Andersen SK; Vígh T; Verreck G; Csontos I; Marosi G; Nagy ZK
    Eur J Pharm Sci; 2021 Sep; 164():105907. PubMed ID: 34118411
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets.
    Koner JS; Rajabi-Siahboomi AR; Missaghi S; Kirby D; Perrie Y; Ahmed J; Mohammed AR
    Sci Rep; 2019 Aug; 9(1):12467. PubMed ID: 31462654
    [TBL] [Abstract][Full Text] [Related]  

  • 152. New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook.
    Elwerfalli AM; Ghanchi Z; Rashid F; Alany RG; ElShaer A
    Curr Drug Deliv; 2015; 12(6):652-67. PubMed ID: 25760951
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Preparation of enteric-coated microcapsules for tableting by spray-drying technique and in vitro simulation of drug release from the tablet in GI tract.
    Takenaka H; Kawashima Y; Lin SY
    J Pharm Sci; 1980 Dec; 69(12):1388-92. PubMed ID: 7463321
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Puzzle out Machine Learning Model-Explaining Disintegration Process in ODTs.
    Szlęk J; Khalid MH; Pacławski A; Czub N; Mendyk A
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456693
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Direct preparation of solid particulates of aminopyrine-barbital complex (pyrabital) from droplets by a spray-drying technique.
    Kawashima Y; Lin SY; Ueda M; Takenaka H; Ando Y
    J Pharm Sci; 1983 May; 72(5):514-8. PubMed ID: 6864497
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Characterization and in vivo efficacy of a heptapeptide ODT formulation for the treatment of neurogenic bladder dysfunction.
    Bae J; Johnston TA; Chaiittianan R; Sutthanut K; Jay M; Marson L
    Int J Pharm; 2018 Jan; 536(1):397-404. PubMed ID: 29195918
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs).
    Chinwala M
    Pharmacy (Basel); 2020 Oct; 8(4):. PubMed ID: 33050437
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique.
    Patel DM; Patel MM
    Indian J Pharm Sci; 2008 Jan; 70(1):71-6. PubMed ID: 20390084
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Development on porous particles of
    Zhou M; Wang Y; Wu F; Shen L; Lin X; Feng Y
    RSC Adv; 2018 Jul; 8(43):24250-24260. PubMed ID: 35539169
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Role of Surface Characteristics of Mannitol in Crystallization of Fenofibrate During Spray Drying.
    Thakur PS; Thakore SD; Bansal AK
    J Pharm Sci; 2020 Feb; 109(2):1105-1114. PubMed ID: 31705872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.